These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15823567)

  • 1. Elevation of Hook1 in a disease model of Batten disease does not affect a novel interaction between Ankyrin G and Hook1.
    Weimer JM; Chattopadhyay S; Custer AW; Pearce DA
    Biochem Biophys Res Commun; 2005 May; 330(4):1176-81. PubMed ID: 15823567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interconnections of CLN3, Hook1 and Rab proteins link Batten disease to defects in the endocytic pathway.
    Luiro K; Yliannala K; Ahtiainen L; Maunu H; Järvelä I; Kyttälä A; Jalanko A
    Hum Mol Genet; 2004 Dec; 13(23):3017-27. PubMed ID: 15471887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcript and in silico analysis of CLN3 in juvenile neuronal ceroid lipofuscinosis and associated mouse models.
    Chan CH; Mitchison HM; Pearce DA
    Hum Mol Genet; 2008 Nov; 17(21):3332-9. PubMed ID: 18678598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revisiting the neuronal localization and trafficking of CLN3 in juvenile neuronal ceroid lipofuscinosis.
    Oetjen S; Kuhl D; Hermey G
    J Neurochem; 2016 Nov; 139(3):456-470. PubMed ID: 27453211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CLN3L, a novel protein related to the Batten disease protein, is overexpressed in Cln3-/- mice and in Batten disease.
    Narayan SB; Pastor JV; Mitchison HM; Bennett MJ
    Brain; 2004 Aug; 127(Pt 8):1748-54. PubMed ID: 15240430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective lysosomal arginine transport in juvenile Batten disease.
    Ramirez-Montealegre D; Pearce DA
    Hum Mol Genet; 2005 Dec; 14(23):3759-73. PubMed ID: 16251196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal ceroid lipofuscinosis protein CLN3 interacts with motor proteins and modifies location of late endosomal compartments.
    Uusi-Rauva K; Kyttälä A; van der Kant R; Vesa J; Tanhuanpää K; Neefjes J; Olkkonen VM; Jalanko A
    Cell Mol Life Sci; 2012 Jun; 69(12):2075-89. PubMed ID: 22261744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CLN3, at the crossroads of endocytic trafficking.
    Cotman SL; Lefrancois S
    Neurosci Lett; 2021 Sep; 762():136117. PubMed ID: 34274435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered gene expression in the eye of a mouse model for batten disease.
    Chattopadhyay S; Kingsley E; Serour A; Curran TM; Brooks AI; Pearce DA
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2893-905. PubMed ID: 15326100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization and processing of CLN3, the protein associated to Batten disease: where is it and what does it do?
    Pearce DA
    J Neurosci Res; 2000 Jan; 59(1):19-23. PubMed ID: 10658181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel interactions of CLN3 protein link Batten disease to dysregulation of fodrin-Na+, K+ ATPase complex.
    Uusi-Rauva K; Luiro K; Tanhuanpää K; Kopra O; Martín-Vasallo P; Kyttälä A; Jalanko A
    Exp Cell Res; 2008 Sep; 314(15):2895-905. PubMed ID: 18621045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of the Batten disease gene CLN3 prevents exit from the TGN of the mannose 6-phosphate receptor.
    Metcalf DJ; Calvi AA; Seaman MNj; Mitchison HM; Cutler DF
    Traffic; 2008 Nov; 9(11):1905-14. PubMed ID: 18817525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CLN3, the protein associated with batten disease: structure, function and localization.
    Phillips SN; Benedict JW; Weimer JM; Pearce DA
    J Neurosci Res; 2005 Mar; 79(5):573-83. PubMed ID: 15657902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CLN3 gene and protein: What we know.
    Mirza M; Vainshtein A; DiRonza A; Chandrachud U; Haslett LJ; Palmieri M; Storch S; Groh J; Dobzinski N; Napolitano G; Schmidtke C; Kerkovich DM
    Mol Genet Genomic Med; 2019 Dec; 7(12):e859. PubMed ID: 31568712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of the batten disease protein CLN3 leads to mis-trafficking of M6PR and defective autophagic-lysosomal reformation.
    Calcagni' A; Staiano L; Zampelli N; Minopoli N; Herz NJ; Di Tullio G; Huynh T; Monfregola J; Esposito A; Cirillo C; Bajic A; Zahabiyon M; Curnock R; Polishchuk E; Parkitny L; Medina DL; Pastore N; Cullen PJ; Parenti G; De Matteis MA; Grumati P; Ballabio A
    Nat Commun; 2023 Jul; 14(1):3911. PubMed ID: 37400440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visual deficits in a mouse model of Batten disease are the result of optic nerve degeneration and loss of dorsal lateral geniculate thalamic neurons.
    Weimer JM; Custer AW; Benedict JW; Alexander NA; Kingsley E; Federoff HJ; Cooper JD; Pearce DA
    Neurobiol Dis; 2006 May; 22(2):284-93. PubMed ID: 16412658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unbiased Cell-based Screening in a Neuronal Cell Model of Batten Disease Highlights an Interaction between Ca2+ Homeostasis, Autophagy, and CLN3 Protein Function.
    Chandrachud U; Walker MW; Simas AM; Heetveld S; Petcherski A; Klein M; Oh H; Wolf P; Zhao WN; Norton S; Haggarty SJ; Lloyd-Evans E; Cotman SL
    J Biol Chem; 2015 Jun; 290(23):14361-80. PubMed ID: 25878248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial correction of the CNS lysosomal storage defect in a mouse model of juvenile neuronal ceroid lipofuscinosis by neonatal CNS administration of an adeno-associated virus serotype rh.10 vector expressing the human CLN3 gene.
    Sondhi D; Scott EC; Chen A; Hackett NR; Wong AM; Kubiak A; Nelvagal HR; Pearse Y; Cotman SL; Cooper JD; Crystal RG
    Hum Gene Ther; 2014 Mar; 25(3):223-39. PubMed ID: 24372003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel interaction of CLN3 with nonmuscle myosin-IIB and defects in cell motility of Cln3(-/-) cells.
    Getty AL; Benedict JW; Pearce DA
    Exp Cell Res; 2011 Jan; 317(1):51-69. PubMed ID: 20850431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten disease.
    Luiro K; Kopra O; Lehtovirta M; Jalanko A
    Hum Mol Genet; 2001 Sep; 10(19):2123-31. PubMed ID: 11590129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.